EUVIMEDEUVIMED entdecken
Crossref

Binding‐Site Directed Selection and Large‐Scale Click‐Synthesis of a Coagulation Factor XIa‐Inhibiting Circular DNA Aptamer

Jie Wang, Yuefei Zhou, Long Sun, Tao Liu, Hao Qu, Yu Mao iD, Lei Zheng

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202404372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Jie Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Factor XIa, Anticoagulants, DNA, Circular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Factor XIa (FXIa) is a plasma protease that catalyzes the intrinsic pathway of blood coagulation, thus being regarded as a promising antithrombotic target. Circular DNA aptamers, with their dramatically enhanced biological and structural stability, hold great potential as new‐generation DNA‐based anticoagulants. However, the functional selection of circular aptamers and large‐scale synthesis of them remains a substantial challenge. In this study, we explored a binding‐site directed selection strategy to enrich circular DNA aptamers that can target the catalytic domain of FXIa and inhibit its function. An asymmetrical dumbbell structured DNA library with self‐shielding primer‐binding site was utilized for selection. This approach has resulted in the identification of a circular DNA aptamer, named FICAPT1, which demonstrates a high binding affinity ( K d =20 nM), notable stability (with a half‐life of 16 h in human plasma) and outstanding anticoagulation activity (with significantly prolonged aPTT), showing great promise as a novel anticoagulant. Moreover, a refined version of FICAPT1, named as CC‐FICAPT1, was quantitatively synthesized (~2 mg/mL) by taking advantage of the pre‐designed structure and high cyclization efficiency of click chemistry. The approach presented in this study enables the efficient generation of functional circular DNA aptamers and allows for their synthesis in a satisfactory scale, making it adaptable for the production of various circular aptamers for therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideFactor XIaAnticoagulantsDNA, CircularHumansBinding SitesClick ChemistryBlood CoagulationSELEX Aptamer Technique

Stichwörter der Autor:innen

binding-site directed selectioncircular aptamerclick-synthesisfactor XIalarge-scale

Substanzen

Aptamers, NucleotideFactor XIaAnticoagulantsDNA, Circular

Autor:innen und Institutionen

  • School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.

ORCID-Profile: Yu Mao

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wang, J., Zhou, Y., Sun, L., Liu, T., Qu, H., Mao, Y., & Zheng, L. (2025). Binding‐Site Directed Selection and Large‐Scale Click‐Synthesis of a Coagulation Factor XIa‐Inhibiting Circular DNA Aptamer. Chemistry – A European Journal. https://doi.org/10.1002/chem.202404372

Vancouver

Wang J, Zhou Y, Sun L, Liu T, Qu H, Mao Y, et al. Binding‐Site Directed Selection and Large‐Scale Click‐Synthesis of a Coagulation Factor XIa‐Inhibiting Circular DNA Aptamer. Chemistry – A European Journal. 2025. doi:10.1002/chem.202404372

BibTeX
@article{Wang2025,
  author = {Wang, Jie and Zhou, Yuefei and Sun, Long and Liu, Tao and Qu, Hao and Mao, Yu and Zheng, Lei},
  title = {Binding‐Site Directed Selection and Large‐Scale Click‐Synthesis of a Coagulation Factor XIa‐Inhibiting Circular DNA Aptamer},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202404372}
}
Kostenlos starten →